Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of antiviral and central nervous system agents. Its structure supports the creation of bioactive molecules due to the presence of the fluorine atom and the pyrrolidinone ring, which enhance metabolic stability and binding affinity. Commonly employed in medicinal chemistry for optimizing drug candidates requiring improved pharmacokinetic properties. Also utilized in the preparation of fluorinated analogs in drug discovery programs.